一种基于DNA甲基化的中枢神经系统肿瘤分类的新型机器学习方法
A Novel Machine Learning Approach for Central Nervous System Tumor Classification from DNA Methylation
AI总结:
提出结合稀疏随机投影降维与多项逻辑回归的机器学习方法,在参考队列上达到96%交叉验证准确率,独立队列上91类准确率86%,优于现有方法。
摘要:
DNA甲基化分析已成为中枢神经系统(CNS)肿瘤分类的有力方法,但在跨队列迁移性、方法学正确性和稳健的多类评估方面仍存在重要挑战。本文提出一种新颖且方法学严谨的基于甲基化的CNS肿瘤分类机器学习方法,该方法将稀疏随机投影用于降维,并结合多项逻辑回归进行分类。我们在广泛使用的参考分类器所建立的相同通用实验设置下评估所提方法。在包含2,801个样本的参考队列上,我们的方法在分层3折交叉验证下达到96%的平均准确率。在独立的1,104个样本临床评估队列上,其在91类级别达到86%的准确率,在甲基化类家族级别评估预测时达到93%的准确率。这些结果优于相应的现有技术参考值(类级别一致性82%,家族级别一致性88%),分别提高了约4和5个百分点。这一改进具有临床意义:在诊断环境中,肿瘤分类正确率提高5个百分点可直接影响癌症亚型分配,进而影响治疗选择和下游临床决策。我们的结果表明,所提模型基于更稳健的机器学习方法学实践,在评估设置中持续优于先前技术,并能实质性地提高CNS肿瘤分类的可靠性。
英文摘要:
NA methylation profiling has become a powerful approach for central nervous system (CNS) tumor classification, yet important challenges remain regarding cross-cohort transferability, methodological correctness, and robust multiclass evaluation. In this work, we propose a novel and methodologically rigorous machine-learning approach for methylation-based CNS tumor classification that combines Sparse Random Projection for dimensionality reduction with multinomial logistic regression for classification. We evaluate the proposed approach in the same general experimental setting established by a widely used reference classifier. On the 2,801-sample reference cohort, our method achieves a mean accuracy of 96\% under stratified 3-fold cross-validation. On the independent 1,104-sample clinical evaluation cohort, it reaches 86\% accuracy at the 91-class level and 93\% when predictions are evaluated at the methylation class family level. These results improve upon the corresponding state-of-the-art reference figures of 82\% class-level concordance and 88\% family-level concordance, yielding absolute gains of approximately 4 and 5 percentage points, respectively. This improvement is clinically relevant: in a diagnostic setting, a 5-point increase in correct tumor classification can directly affect cancer subtype assignment and, in turn, influence treatment selection and downstream clinical decision-making. Our results show that the proposed model, grounded in stronger methodological practice in machine learning, consistently outperforms the previous state of the art across evaluation settings and can materially improve the reliability of CNS tumor classification.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。